CD8A and myeloid sarcoma: Together, these observations point toward a multifaceted role of SQAPLPCVL-specific, HLA-E-restricted CD8+ T cells in EBV immunity and MS, and their impact may depend on the interplay between host HLA-E genotype, EBV infection history, and disease subtype and stage.